Therapeutic zinc and copper supplementation in acute diarrhea does not influence short-term morbidity and growth: double-blind randomized controlled trial

Pediatr Infect Dis J. 2013 Jan;32(1):91-3. doi: 10.1097/INF.0b013e31826fb32d.

Abstract

Our objective was to evaluate the effect of zinc and copper supplementation in acute diarrhea on morbidity and growth during 12 weeks of follow-up. In a double-blind randomized controlled clinical trial of 724 children aged 6-59 months, none of the 11 evaluated outcomes showed significant association with zinc or zinc and copper supplementation. Thus, therapeutic zinc supplementation may not always yield short-term -benefits.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Administration, Oral
  • Analysis of Variance
  • Body Size / drug effects
  • Chi-Square Distribution
  • Child, Preschool
  • Copper / administration & dosage*
  • Diarrhea / diet therapy*
  • Dietary Supplements
  • Double-Blind Method
  • Humans
  • Infant
  • Morbidity
  • Treatment Outcome
  • Zinc / administration & dosage*

Substances

  • Copper
  • Zinc